HomePharma

Pharma

Pharma

Argobio and GeneCode Partner on Parkinson’s Disease in Argobio’s First Announced Research Agreement

Life Sciences Times - 0
Pharma

First Subjects Dosed in First-in-Human Trial for VarmX’s Anticoagulant Reversal Agent, VMX-C001

Life Sciences Times - 0
Pharma

Laurent Pharmaceuticals Extends COVID-19 Phase 2 Study with Oral Antiviral LAU-7b that has Showed 100% Reduction in the Risk of Progression onto Mechanical Ventilation...

Life Sciences Times - 0
Pharma

LEO Pharma Initiates a Phase 2b Dose-Ranging Clinical Trial With an Oral H4R Antagonist in Adult Patients With Moderate-to-Severe Atopic Dermatitis

Life Sciences Times - 0
Pharma

Ubiquigent celebrates milestone anniversary of DUBprofiler™ compound profiling platform

Life Sciences Times - 0
Pharma

Two-Year Analysis of CARTITUDE-1 Shows Early, Durable and Deepening Responses of Ciltacabtagene Autoleucel (cilta-cel) in Heavily Pretreated Patients with Multiple Myeloma

Life Sciences Times - 0
Pharma

Lifespin GmbH Secures €2.5M Bridge Financing to Further Build its AI-Enabled Metabolomics-Based Differential Diagnosis Panel for Neurological Diseases

Life Sciences Times - 0
Pharma

4D Pharma Announces Positive Topline Results From Part a of Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma

Life Sciences Times - 0
Pharma

Rocket Pharmaceuticals Presents Positive Clinical Data from Company’s Lentiviral Gene Therapies for Treatment of Fanconi Anemia, LAD-I and PKD

Life Sciences Times - 0
Pharma

Trodelvy® Demonstrates Clinical Benefit for Black Patients Consistent with Full Metastatic Triple-Negative Breast Cancer Population in ASCENT Study

Life Sciences Times - 0
Pharma

BeiGene Presents Results from Phase 3 Trial of Tislelizumab in Nasopharyngeal Cancer at ESMO Immuno-Oncology Congress 2021

Life Sciences Times - 0
Pharma

Deep Knowledge Group: Deep Pharma Intelligence Releases Analytical Study “5 High-impact Cancer Vaccine Platforms”

Life Sciences Times - 0
1...656667...91Page 66 of 91

Most Read